Login / Signup

Generalizability of FIGARO-DKD and FIDELIO-DKD Trial Criteria to the US Population Eligible for Finerenone.

Nicholas ChiuRahul AggarwalGeorge L BakrisBertram PittDeepak L Bhatt
Published in: Journal of the American Heart Association (2022)
Keyphrases
  • phase iii
  • study protocol
  • clinical trial
  • phase ii
  • randomized controlled trial
  • open label